Home / Restatements / VSEE HEALTH, INC.
Filed 2025-08-28 路 Form 8-K 路 Accession 0001104659-25-084843 nano
Price before filing: $67.6 (2025-08-27 close, split/dividend-adjusted)
Market cap at flag: $12.7M (2025-08-28) 路 Latest: $1.4M (2026-10-01)
| Window | VSEE | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -25.9% | +2.9% | -28.8% | 2025-09-29 |
| 90 days | -36.1% | +5.4% | -41.5% | 2025-11-26 |
| 180 days | -60.3% | +6.9% | -67.2% | 2026-02-24 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On July 17, 2025, management of the Company, in consultation with the Company's Board of Directors (including the members of the Audit Committee thereof), concluded that the Prior Financial Statements (other than the March 31, 2023 and March 31, 2024 consolidated financial statements of VSee Lab) should no longer be relied upon due to the impact of the errors noted below and will be restated."
Quoted from the filing. Source
The company says previously issued financial statements should no longer be relied upon (8-K Item 4.02). This is one of the most serious accounting red flags: past reported numbers were wrong and will be restated.
Why this score: also within 90 days: Auditor change, Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.